No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr5:61023200-61028800 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
2 |
chr5:61025800-61028000 |
Enhancers |
Fetal Brain Female |
brain
|
3 |
chr5:61026000-61029200 |
Enhancers |
Fetal Brain Male |
brain
|
4 |
chr5:61026400-61027800 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
5 |
chr5:61026400-61027800 |
Enhancers |
Brain Hippocampus Middle |
brain
|
6 |
chr5:61026400-61028000 |
Enhancers |
Brain Anterior Caudate |
brain
|
7 |
chr5:61026400-61028400 |
Enhancers |
HUES64 Cell Line |
embryonic stem cell
|
8 |
chr5:61026600-61028000 |
Enhancers |
Brain Cingulate Gyrus |
brain
|
9 |
chr5:61026600-61028000 |
Enhancers |
Brain Germinal Matrix |
brain
|
10 |
chr5:61026600-61028400 |
Enhancers |
Liver |
Liver
|
11 |
chr5:61026800-61027800 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
12 |
chr5:61026800-61028000 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
13 |
chr5:61026800-61029400 |
Enhancers |
Fetal Stomach |
stomach
|
14 |
chr5:61027000-61027800 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
15 |
chr5:61027000-61027800 |
Bivalent/Poised TSS |
Breast Myoepithelial Primary Cells |
Breast
|
16 |
chr5:61027000-61027800 |
Enhancers |
Brain Angular Gyrus |
brain
|
17 |
chr5:61027000-61028000 |
Enhancers |
Brain Substantia Nigra |
brain
|
18 |
chr5:61027000-61029200 |
Flanking Active TSS |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
19 |
chr5:61027200-61028200 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
20 |
chr5:61027200-61028200 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
21 |
chr5:61027400-61028000 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
22 |
chr5:61027400-61032400 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
23 |
chr5:61027600-61027800 |
Flanking Active TSS |
H1 Cell Line |
embryonic stem cell
|
24 |
chr5:61027600-61027800 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
25 |
chr5:61027600-61027800 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
26 |
chr5:61027600-61027800 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
27 |
chr5:61027600-61027800 |
Flanking Active TSS |
Brain Inferior Temporal Lobe |
brain
|
28 |
chr5:61027600-61027800 |
Enhancers |
Duodenum Smooth Muscle |
Duodenum
|
29 |
chr5:61027600-61027800 |
Flanking Active TSS |
Ovary |
ovary
|
30 |
chr5:61027600-61027800 |
Active TSS |
Stomach Smooth Muscle |
stomach
|
31 |
chr5:61027600-61028200 |
Enhancers |
Colon Smooth Muscle |
Colon
|
32 |
chr5:61027600-61028200 |
Enhancers |
Fetal Kidney |
kidney
|
33 |
chr5:61027600-61028400 |
Flanking Active TSS |
Fetal Lung |
lung
|
34 |
chr5:61027600-61028400 |
Enhancers |
Placenta |
Placenta
|
35 |
chr5:61027600-61028600 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
36 |
chr5:61027600-61028800 |
Active TSS |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
37 |
chr5:61027600-61029000 |
Enhancers |
Pancreas |
Pancrea
|
38 |
chr5:61027600-61029200 |
Enhancers |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
39 |
chr5:61027600-61030600 |
Enhancers |
iPS DF 19.11 Cell Line |
embryonic stem cell
|